[go: up one dir, main page]

WO2006116678A3 - Ciblage tissulaire de cellules souches - Google Patents

Ciblage tissulaire de cellules souches Download PDF

Info

Publication number
WO2006116678A3
WO2006116678A3 PCT/US2006/016235 US2006016235W WO2006116678A3 WO 2006116678 A3 WO2006116678 A3 WO 2006116678A3 US 2006016235 W US2006016235 W US 2006016235W WO 2006116678 A3 WO2006116678 A3 WO 2006116678A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
tissue targeting
vivo
stem cell
unique
Prior art date
Application number
PCT/US2006/016235
Other languages
English (en)
Other versions
WO2006116678A2 (fr
Inventor
Maria Grant
Sean Sullivan
Original Assignee
Univ Florida
Maria Grant
Sean Sullivan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida, Maria Grant, Sean Sullivan filed Critical Univ Florida
Publication of WO2006116678A2 publication Critical patent/WO2006116678A2/fr
Publication of WO2006116678A3 publication Critical patent/WO2006116678A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des compositions de cellules souches comprenant un gène particulier au tissu greffé désiré, qui est introduit dans la cellule souche soit ex vivo soit in vivo. En conséquence de l'expression du gène particulier, la cellule souche se niche et se différencie en le type de cellule souhaité en un emplacement spécifique in vivo.
PCT/US2006/016235 2005-04-28 2006-04-28 Ciblage tissulaire de cellules souches WO2006116678A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67576905P 2005-04-28 2005-04-28
US60/675,769 2005-04-28

Publications (2)

Publication Number Publication Date
WO2006116678A2 WO2006116678A2 (fr) 2006-11-02
WO2006116678A3 true WO2006116678A3 (fr) 2007-08-02

Family

ID=37215544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/016235 WO2006116678A2 (fr) 2005-04-28 2006-04-28 Ciblage tissulaire de cellules souches

Country Status (1)

Country Link
WO (1) WO2006116678A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816140B2 (en) 2005-06-14 2010-10-19 The United States Of America As Represented By The Department Of Veterans Affairs Composition and methods for osteogenic gene therapy
DE102006005827B3 (de) * 2006-02-08 2007-07-26 Torzewski, Jan, Prof. Dr. med. mRNA-Transfektion von adulten Progenitorzellen zur spezifischen Gewebsregeneration
EP2404609A1 (fr) * 2010-07-07 2012-01-11 Deutsches Krebsforschungszentrum Utilisation d'un parvovirus pour éliminer des cellules souche cancéreuses (CSC)
EP2622062A4 (fr) 2010-10-01 2014-05-14 Univ Columbia Ecotropisme cellulaire induit par pdgf

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153383A (en) * 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
US20020086383A1 (en) * 2000-02-23 2002-07-04 Guy Sauvageau Hematopoietic stem cell expansion enhancing factor and method of use
US20020099196A1 (en) * 1996-08-27 2002-07-25 Kyowa Hakko Kogyo Co., Ltd. And Atsunobu Hiraoka Hematopoietic stem cell growth factor (scgf)
US20050063961A1 (en) * 2002-07-25 2005-03-24 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099196A1 (en) * 1996-08-27 2002-07-25 Kyowa Hakko Kogyo Co., Ltd. And Atsunobu Hiraoka Hematopoietic stem cell growth factor (scgf)
US6153383A (en) * 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
US20020086383A1 (en) * 2000-02-23 2002-07-04 Guy Sauvageau Hematopoietic stem cell expansion enhancing factor and method of use
US20050063961A1 (en) * 2002-07-25 2005-03-24 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Also Published As

Publication number Publication date
WO2006116678A2 (fr) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2007064846A3 (fr) Compositions et procedes d'utilisation d'arnsi pour inactiver l'expression genique et ameliorer la transplantation d'organes solides et de cellules
WO2006084209A3 (fr) Produits de synthese d'expression d'arni
IL158543A0 (en) Homing of embryonic stem cells to a target zone in tissue using active therapeutics of substances
WO2006050330A3 (fr) Plaquettes de cellules souches
GB2441488B (en) Suspension culture of human embryonic stem cells
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
WO2006026570A3 (fr) Utilisation de cellules souches pour generer des cellules de l'oreille interne
EP4223769A3 (fr) Facteur de reprogrammation nucléaire
WO2009020201A1 (fr) Masse cellulaire isolée
WO2008085221A3 (fr) Utilisation thérapeutique de cellules exprimant cd31
WO2008056173A3 (fr) Cellules pluripotentes provenant de la couche de l'épiblaste tardif de mammifères
IL180437A0 (en) Shape and dimension maintenance of soft tissue grafts by stem cells
IL158542A0 (en) Homing of autologous cells to a target zone in tissue using active therapeutics or substances
EP2727998A3 (fr) Procédés pour la purification de cellules endodermiques pancréatiques issues de cellules souches embryonnaires humaines
NZ612132A (en) Immunomodulation using placental stem cells
WO2007149861A3 (fr) Réparation de tissu mou et régénération à l'aide des produits de cellules souches
WO2007146980A3 (fr) Epsp synthases améliorées, compositions et procédés d'utilisation
WO2006093857A3 (fr) Procede de production d'une substance cellulaire facilement disponible derivee du sang peripherique et composition de cette substance
WO2006081435A3 (fr) Procede d'obtention de materiau cellulaire derive de sang de cordon facilement utilisable, et compositions correspondantes
NZ603805A (en) Methods for increasing and mobilizing hematopoietic stem cells
WO2006125025A3 (fr) Matrices extracellulaires de synthese regulant le comportement des cellules souches
WO2007089627A3 (fr) Procédés et compositions se rapportant à la transplantation de cellules souches
ZA200805210B (en) Methods of improving stem cell homing and engraftment
WO2005121323A3 (fr) Methodes de propagation ex vivo de cellules souches somatiques du follicule pileux
WO2009047568A3 (fr) Conservation in vitro de cellules animales vivantes et composés appropriés pour être utilisés dans la conservation de cellules animales vivantes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06751761

Country of ref document: EP

Kind code of ref document: A2